Principal Investigator
Fernando Corrales Medina
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20260196
Clinical Trial Summary
A MULTICENTER, RANDOMIZED, OPEN LABEL, PHASE III CLINICAL TRIAL TO EVALUATE THE EFFICACY, SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF NXT007 PROPHYLAXIS VERSUS EMICIZUMAB PROPHYLAXIS IN PEOPLE WITH HEMOPHILIA A
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other
Contact Information
Study Contact
Leandro Pisani
Phone Number
+1 (305) 2436925
Email
lfp34@miami.edu